Analysis of hospitalizations of patients with penile cancer: A national population-based study.

Authors

Philip Kanemo

Philip Onyekaoso Kanemo

Rapides Regional Medical Center, Alexandria, LA

Philip Onyekaoso Kanemo , Ted Akhiwu , Ayobami Gbenga Olafimihan , Ehizogie Edigin , Anthonia Ijeli , Muhammad Bilal Ibrahim , Osaigbokan Aihie , Dan Ran Castillo , Muhammad Nauman Riaz

Organizations

Rapides Regional Medical Center, Alexandria, LA, MedStar Health, Baltimore, MD, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, loma linda University, Loma Linda, California, Loma Linda, CA, Springfield Clinic, Lincoln memorial Hospital, Lincoln, IL, School of Medicine, University of Missouri, Columbia, MO, Division of Medical Oncology and Hematology, Loma Linda University School of Medicine, Loma Linda, CA

Research Funding

No funding received
None.

Background: Penile cancer (PC) is a rare malignancy that is more common in developing countries. However, recent studies have shown rising incidence-based mortality in the United States (U.S). National population data is scarce on reasons for hospitalizations, epidemiology, and hospitalization outcomes of patients with PC. Methods: Data were abstracted from the National Inpatient Sample (NIS) 2020 Database. T≥his database is the largest collection of inpatient admission data in the U.S. It is a 20-percent stratified sample of all discharges from U.S. community hospitals, excluding rehabilitation and long-term acute care hospitals. The numbers in the databases are weighted to optimize national estimates. Hospitalizations for patients with PC were obtained by searching for hospitalizations that contained the International Classification of Diseases (ICD)-10 code “C60” as a principal or secondary diagnosis. The principal diagnosis is the main reason for the admission, while any other diagnosis other than the principal, are secondary diagnosis. The reason for hospitalization (or principal diagnosis) was recorded in descending order of frequency based on the ICD-10 code organ system category and specific principal diagnosis. The total number of PC discharges, baseline demographic characteristics, hospital length of stay (LOS), and total hospital charges were recorded. STATA 16 was used for analysis. Since NIS contains de-identified data, Institutional Review Board (IRB) review was waived. Results: There were 32 million discharges included in the 2020 NIS database. Of those, 2,785 hospitalizations were for patients aged ≥18 years, who had either a principal or secondary ICD 10 code for PC. Patients were predominantly white (65.9%), mean age of 66.5 years, inpatient mortality of 4.7%, mean LOS of 6.1 days, and mean total hospital charge of 71,447 U.S dollars. The 7 most common reasons for hospitalization by ICD 10 code categories were neoplasm and hematological (35.9%), nonspecific (17.3%), infections (12.6%), injury & poisoning (7.1%), cardiovascular (6.4%), and Genito-urinary (4.3%). The 5 most common specific principal diagnoses for hospitalizations were malignant neoplasm of the penis (29.1%), admission for chemotherapy (12.7%), sepsis (2.7%), Malignant neoplasm of the glans penis (2.2%), secondary neoplasm of inguinal and lower limb nodes (1.8%). Conclusions: Hospitalized PC patients are mostly elderly white men. Infections, chemotherapy, and PC were the most common reasons for hospitalizations. Optimal management of underlying malignancy, prevention, and prompt treatment of infections in the outpatient is important in reducing hospitalizations of these patients.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2023 ASCO Annual Meeting

Session Type

Publication Only

Session Title

Publication Only: Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Penile Cancer

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr e17033)

DOI

10.1200/JCO.2023.41.16_suppl.e17033

Abstract #

e17033

Abstract Disclosures

Similar Abstracts

First Author: Arun Kumar

Abstract

2024 ASCO Genitourinary Cancers Symposium

Impact of HIV-HPV co-infection on inpatient penile cancer outcomes.

First Author: Ayobami Gbenga Olafimihan